1. Introduction {#sec0005}
===============

Hepatitis E virus (HEV) is a common cause of waterborne acute viral hepatitis in developing countries. Though hepatitis E is recognized as self limiting disease in general population, for unknown reasons pregnant women are more prone to infection and development of fulminant hepatic failure (FHF) with fatality rates approaching 15--20% ([@bib0095]). In industrialized countries zoonosis is the major cause of hepatitis ([@bib0130]).

HEV is non-enveloped virus, approximately 27--34 nm in diameter and belongs to genus *Hepevirus* in the family *Hepeviridae*. HEV genome is linear, single-stranded positive sense RNA of about 7.2 kb. The genome has short 5′- and 3′-untranslated regions, a 5′-methylguanine cap, a 3′ poly (A) stretch, and three open reading frames ORF1, ORF2 and ORF3. ORF1 codes for viral non-structural polyprotein and contains several conserved enzymatic domains, including putative methyltransferase, papain like cysteine protease, helicase and RNA-dependent RNA polymerase ([@bib0100]). ORF2 codes for viral capsid protein and ORF3 for a small phosphoprotein that gets associated with cellular membranes and cytoskeleton fractions ([@bib0160]). ORF3 also has pleiotropic effects on host cell pathways and recently reported to have an important role in viral egress from infected cell ([@bib0005], [@bib0065]). HEV has been classified phylogenetically into four major genotypes 1, 2, 3 and 4. Genotypes 1 and 2 are restricted to humans and cause sporadic and epidemic hepatitis, mostly in developing countries. Genotypes 3 and 4 HEV are zoonotic and infect humans and wide range of animal species (International Committee for Taxonomy of Viruses; Ninth Report).

Helicases are molecular motor proteins that unwind nucleic acid strands using ATP derived energy and have important role during virus replication ([@bib0080]). Most positive sense RNA viruses encode their own RNA helicases with highly conserved domains. In addition to the viral genome replication, helicases are also involved in RNA translocation, genome packaging/unpackaging, protecting RNA at replication site, modulating RNA--protein interactions, capping etc. Helicases can also interact with host cell proteins and help in establishing virus infection.

Hepatitis E virus RNA helicase has been grouped into 5′--3′ class of superfamily 1 of helicases (SF1) containing seven signature motifs (I, Ia, II, III, IV, V and VI). These highly conserved motifs are also found in positive sense RNA viruses such as alphaviruses, arteriviruses, coronaviruses and rubiviruses. We have previously reported that HEV helicase has nucleotide triphosphatase (NTPase) activity and is able to hydrolyze all NTPs, although with differential efficiencies. The enzyme has ability to unwind RNA duplexes with 5′ overhangs and has sequence independent RNA-5′-triphosphatase (RTPase) activity suggestive of its role in forming viral cap structure.

Severity of HEV infection in pregnant women still remains a major question in HEV pathogenesis. Exact mechanism of liver damage in HEV infection is not yet known. Studies from our group have shown significantly higher levels of both Th1 (IFN-γ, IL-2 and TNF-α) and Th2 (IL-10) cytokines in FHF-E patients ([@bib0145]) and association of TNF-α and IFN-γ cytokine gene polymorphism with the susceptibility and clinical outcome of hepatitis E ([@bib0120]). [@bib0140] have shown increased number of CD8+T cells in the liver biopsies of HEV infected patients suggesting their role in liver damage. Impairment of HEV specific T-cell responses was shown to be associated with chronic HEV infection in immunocompromised organ transplant patients ([@bib0150]). It is not yet clear whether severity of HEV infection is influenced alone by the host factors or there is involvement of viral factors also.

There are studies indicating association of point mutations in HEV genome with disease severity; however underlying mechanism still remains unknown. Silent substitutions of U at the nucleotide 3148 (in the helicase domain) and C at the nucleotide 5907 (in the capsid gene) in HEV strains of genotype 3 (comparison between 10 acute and 1 FHF case) and 4 (comparison between 23 acute and 5 FHF cases) have been documented to have association with fulminant hepatitis and disease severity in patients. C5907 was also associated with high viral loads in the infected individuals ([@bib0070], [@bib0075]). [@bib0155] have reported association of V239A mutation (in the helicase domain) (7/7 severe hepatitis cases) with increased virulence of genotype 3 virus. Similarly, comparative sequence analysis of genotype 1 sequences from acute viral hepatitis cases from India, Indian subcontinent and FHF cases from India showed sub clustering of 6/7 FHF sequences indicative of similarity in them. There were six unique amino acid substitutions in the ORF1 region of HEV sequences derived from FHF cases (F179S, A317T, T735I, L1110F, V1120I, and F1439Y) ([@bib0125]). Two of these mutations L1110F (found in 5/7 FHF virus sequences) and V1120I (6/7 FHF virus sequences) were present in the HEV helicase region, between helicase motif IV and motif V. These reports suggested possible involvement of helicase domain in determining outcome of HEV infections. Present study addresses possible role of L1110F and V1120I amino acid replacements in the helicase domain of genotype 1 virus in altering enzymatic activities of the protein and replication efficiency of the virus.

2. Materials and methods {#sec0010}
========================

2.1. Cells {#sec0015}
----------

S10-3 cells (a subclone of the human hepatoma Huh7 cells) were a kind gift from Dr. S. Emerson (NIH, USA) and were maintained as described previously ([@bib0050]).

2.2. Cloning, expression and purification of HEV NTPase/helicase domain {#sec0020}
-----------------------------------------------------------------------

The HEV helicase domain (amino acids 960--1204 of HEV ORF1) clone (pET15b.HEV Hel) from genotype 1 virus was previously constructed in our laboratory (GenBank Accession No. [DQ459342](ncbi-n:DQ459342){#intr0005}) ([@bib0085]). The *Escherichia coli* BL21 (DE3)/RIPL codon plus cells (Stratagene, La Jolla, CA) were transformed with recombinant plasmid for protein expression. Protein induction was done with 1.0 mM IPTG for 2 h at 37 °C. The N-terminal His tag fusion protein was purified from bacterial culture pellets using ProBond nickel chelating resin column (Invitrogen) in denatured condition. Briefly, cell pellet was lysed by using buffer containing 6 M guanidine hydrochloride, 50 mM HEPES buffer (pH 7.8) and 0.5 M NaCl. Cell lysate was centrifuged at 10,000 ×  *g* for 40 min and supernatant was loaded on to column pre-equilibrated with binding buffer (8 M urea, 0.5 M NaCl, 50 mM HEPES buffer, pH 7.8). Washing was done initially with wash buffer 1 (8 M urea, 0.5 M NaCl, 50 mM HEPES, pH 6.0) followed by wash buffer 2 (8 M Urea, 0.5 M NaCl, 50 mM HEPES, pH 5.3). Elution of the protein was performed using elution buffer (8 M urea, 0.5 M NaCl, 50 mM HEPES buffer, pH 4.0). Collected fractions were analyzed on 10% SDS-PAGE. Fractions containing protein of expected size were combined and concentrated using Amicon membrane columns (cutoff: 10 kDa) (Millipore).

Renaturation/refolding of the purified protein was done by incubating the protein overnight in buffer containing 50 mM HEPES (pH 7.2), 1 M PPS, 1 mM dithiothreitol (DTT) at 4 °C followed by quick dialysis in 50 mM HEPES buffer. Western blot analysis was done using anti-His monoclonal antibodies (Sigma Chemicals, St. Louis, MO). Protein concentration was determined by the Bradford\'s method. Glycerol, DTT, protease inhibitor (Roche) were added to the final concentrations of 20%, 2 mM and 1× respectively, and the protein was stored at −80 °C in aliquots until use.

2.3. Generation of helicase protein mutants by site directed mutagenesis {#sec0025}
------------------------------------------------------------------------

Construction of the Walker A motif (motif I) and Walker B motif (motif II) helicase mutants is previously reported ([@bib0085]). Mutants L1110F Hel, V1120I Hel and L1110F/V1120I Hel were generated with primers pairs as listed in the [Table 1](#tbl0005){ref-type="table"} using pET15b.HEV Hel clone as the template with QuickChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA). Clones were confirmed by sequencing and host *E. coli* BL21 cells were transformed with these plasmids. Protein induction and purification were carried out as described above.Table 1DNA oligonucleotides used in this study.NameSequence (5′--3′)MerL1110F Hel ForGACCACTAGCCGGGTTTTCCGTTCGTTGTT30L1110F Hel RevAACAACGAACGGAAAACCCGGCTAGTGGTC30V1120I Hel ForCTGGGGTGAGCCTGCCATCGGGCAGAAACTAGTG34V1120I Hel RevCACTAGTTTCTGCCCGATGGCAGGCTCACCCCAG34Mut GDD ForGTGGCTGCCTTTAAAGGTGCTGCTTCGATAGTGCTTTGC39Mut GDD RevGCAAAGCACTATCGAAGCAGCACCTTTAAAGGCAGCCAC39Mut GKS ForGGTGTGCCTGGATCCGGCGCGTCCCGCTCTATTACC36Mut GKS RevGGTAATAGAGCGGGACGCGCCGGATCCAGGCACACC36Mut DE ForGGGCGCCGGGTTGTCATTGCTGCGGCCCCGTCCCTTC37Mut DE RevGAAGGGACGGGGCCGCAGCAATGACAACCCGGCGCCC37Mut L1110F ForACCACTAGTCGGGTCTTCCGGTCGTTGTTCTGG33Mut L1110F RevCCAGAACAACGACCGGAAGACCCGACTAGTGGT33Mut V1120I ForGGTGAGCCCGCCATTGGGCAGAAGCTAGTGTTC33Mut V1120I RevGAACACTAGCTTCTGCCCAATGGCGGGCTCACC33

2.4. ATPase assay {#sec0030}
-----------------

ATPase assays were performed by sensitive and high throughput colorimetric method as described earlier ([@bib0085]). Briefly, reaction was performed in a 96-well plate using malachite green reagent. The 50 μl reaction contained, 300 pmol of enzyme, 50 mM HEPES (pH 7.2), 2 mM MgCl~2~, 10 mM KCl, 0.05 mg of BSA/ml, 2 mM DTT and 0.1 mM NTP. After incubation at 37 °C for 40 min color was developed by adding of an equal volume of malachite green-molybdate reagent and further incubating at room temperature for 30 min. The absorbance was measured at 630 nm by using μQuant 96-well plate reader (Bio-Tek). All reactions were carried out in triplicates, in two independent experiments and mean values were taken to calculate the NTPase activity in the form of amount of inorganic phosphate released through hydrolysis of NTP using the standard curve (made by using known concentrations of potassium dihydrogen phosphate). Comparative activities of mutant proteins were derived by assuming the activity of wild type helicase protein as 100%. The kinetic parameters (*K* ~m~, *V* ~max~) were calculated by using the double reciprocal plot. Briefly, each mutant protein (300 pmoles) was incubated with ATP at different concentrations from 2.5 μM to 100 μM. The reciprocals of substrate hydrolysis (1/V) were plotted against the reciprocals of substrate concentrations (1/\[S\]). Mean values from two independent experiments performed in triplicates were taken to calculate *K* ~m~ (μM) and *V* ~max~ (nmoles min^−1^  mg^−1^) values by fitting the data using MS excel 2007.

2.5. RNA unwinding assay {#sec0035}
------------------------

RNA unwinding assays were performed by non-radioactive ELISA based method as described previously ([@bib0115]). Briefly, RNA duplexes were generated by annealing in vitro synthesized, biotin labeled 38 mer RNA (binding strand) and Digoxigenin (DIG) labeled 26 mer RNA strand (release strand). The biotin ylated strand binds to the streptavidin-coated wells while the helicase catalyzes removal of DIG labeled strand. DIG-labeled strand is detected using anti-DIG antibodies coupled to horseradish peroxidase which gives amount of intact RNA duplex after the enzymatic action. Taking absorbance thus allows indirect measurement of unwinding efficiency of the enzyme, i.e. decrease in absorbance is proportional to unwinding by the enzyme. All reactions were carried out in triplicates, in two independent experiments and mean values were taken to calculate percent unwinding activities of the helicase mutants.

2.6. Generation of mutants of HEV subgenomic replicon {#sec0040}
-----------------------------------------------------

HEV Rluc replicon encoding *Renilla* luciferase (Rluc) gene was a kind gift from Dr. X.J. Meng (Virginia Tech, Blacksburg, USA). This subgenomic clone was developed by them from pSKHEV-2, genotype 1 HEV infectious cDNA clone (GenBank Accession No. [AF444002](ncbi-n:AF444002){#intr0010}) ([@bib0030]). Following replicon mutants were developed using HEV-Rluc replicon as the template by site directed mutagenesis in the current study: Mut GKS (changing G[K]{.ul}S to G[A]{.ul}S in the Walker A motif), Mut DE (changing [DE]{.ul} to [AA]{.ul} in the Walker B motif), Mut L1110F, Mut V1120I, Mut L1110F/V1120I and Mut GDD (changing conserved RdRp GDD motif to G[AA]{.ul} was previously shown to completely stop HEV replication by [@bib0055], [@bib0030]). The primer sequences used for construction of the mutant clones are given in [Table 1](#tbl0005){ref-type="table"}.

2.7. Generation of capped RNA transcripts and transfection {#sec0045}
----------------------------------------------------------

HEV replicon plasmids were linearized by utilizing unique BglII site located immediately downstream of the poly (A) tract of the HEV sequence and capped RNA transcripts were synthesized by in vitro transcription using mMessage mMachine T7 ultra kit (Ambion). Following transcription, DNA template was removed by DNase I treatment, transcribed RNA was purified by lithium chloride precipitation method as per the manufacturer\'s instructions and quantified on Nanodrop spectrophotometer (ND-1000, Nanodrop technologies). Integrity of the transcripts was checked by doing denaturing agarose gel electrophoresis. For each experiment, S10-3 cells were grown up to 60--70% confluence in 24-well cell culture plates and washed with serum free medium, OptiMEM (Invitrogen, Life technologies) prior to transfection. Capped RNA transcripts, diluted appropriately in the OptiMEM were transfected in cells (2 μg/well of the 24 well plate) using 1,2-dimyristyl Rosenthal inhibitor ether (DMRIE-C) reagent (Invitrogen) as per the manufacturer\'s instructions. Firefly luciferase plasmid DNA was co-transfected (PGL-3 promoter vector, 100 ng/well) with HEV-Rluc RNA to normalize cell transfection efficiency and the *Renilla* luciferase signal. After 4 h of incubation at 34.5 °C, transfection mixture was replaced with DMEM containing 10%FBS. All transfections were carried out in triplicates and each set of experiments was repeated twice.

### 2.7.1. Reporter gene assay {#sec0050}

Monolayer of the RNA transfected cells was washed two times with phosphate buffered saline, cells were lysed in 100 μl of 1× Passive Lysis Buffer (Promega) and the lysates were immediately frozen at −80 °C until use. For the assay, samples were thawed, centrifuged at 5000 RPM for 2 min and 20 μl cell extracts were used for measuring the dual luciferase activities (Renilla luciferase: RLuc and firefly luciferase: Luc) using Dual luciferase assay system (Promega) and readings were taken on the Perkin Elmer 2030 Reader (Victor X3). RLuc values were divided with Luc values to normalize transfection efficiencies.

2.8. Detection of HEV replicative intermediate (negative strand RNA) by strand specific RT-PCR {#sec0055}
----------------------------------------------------------------------------------------------

S10-3 cells were transfected with capped RNA transcripts as described above, incubated at 34.5 °C for 4 h, the transfection mixture was removed and the cell monolayer was washed 10 times with 1× PBS. RNA transfected cells were harvested at different time intervals and cell pellets were processed for the total cellular RNA extraction using Ribopure kit (Ambion Life technologies, USA) as per the manufacturer\'s instructions. Detection of negative sense RNA (nsRNA) (replicative intermediate) was done using strand specific tagged primer-based reverse-transcription PCR as described previously ([@bib0035]).

3. Results {#sec0060}
==========

3.1. Construction of HEV helicase mutants, protein expression and purification {#sec0065}
------------------------------------------------------------------------------

We have previously reported cloning and expression of helicase domain protein ([@bib0085]). On comparison of Indian FHF-E derived HEV helicase domain sequences with this expression construct, except for the two amino acid changes (L1110F and V1120I) remaining sequences were 100% identical. Hence this helicase domain clone was used as the template to develop FHF helicase mutant clones in view of checking their enzymatic activities. Three mutant proteins were generated by site directed mutagenesis (L1110F Hel, V1120I Hel and L1110F/V1120I Hel) while previously developed Walker A (G[K]{.ul}S to G[A]{.ul}S) and Walker B ([DE]{.ul} to [AA]{.ul}) mutant proteins ([@bib0085]) were used for comparison in the present study. Locations of point mutations in the HEV helicase encoding region are shown in the schematic diagram of the helicase in [Fig. 1](#fig0005){ref-type="fig"} . All proteins were expressed along with N-terminal fusion histidine tag and purified using nickel affinity chromatography in denaturing buffer system followed by refolding in renaturing buffer ([@bib0115]). Renaturation of the proteins was monitored by doing ATPase assay of the wild type protein, purified in parallel with mutants in identical buffer conditions and at similar protein concentrations. Overall, protein purity was more than 90% for all proteins. All mutants including wild type protein showed identical band size (26 kDa) when analyzed by 10% SDS-PAGE ([Fig. 2](#fig0010){ref-type="fig"}A) and western blot ([Fig. 2](#fig0010){ref-type="fig"}B).Fig. 1Schematic representation of hepatitis E virus ORF1: HEV ORF1 region encodes nonstructural polyprotein that contains methyltransferase (MeT), Y, papain-like cysteine protease (PCP), variable (V), X (macro), RNA helicase (Hel), and RNA-dependent RNA polymerase (RdRp) domains. The conserved motifs, typical of the helicase superfamily I (designated as I--VI) are shown in the enlarged view of HEV helicase (960--1204 aa). The amino acid changes done in the helicase region of pET15b.HEV Hel expression clone and HEV Rluc replicon are indicated in 'Bold' text.Fig. 2SDS-PAGE and Western blot analysis: (A) SDS-PAGE (10%) analysis of wild-type and mutant helicase proteins (Walker A motif, Walker B motif, L1110F Hel, V1120I Hel and L1110F/V1120I Hel), (B) Western blot analysis was carried out using anti-histidine monoclonal antibodies.

3.2. ATP hydrolysis activity of helicase mutants {#sec0070}
------------------------------------------------

Comparative analysis of ATPase activities of the mutant helicase proteins was done using equimolar amounts of purified proteins (300 pmoles/assay) as reported previously ([@bib0115]). Reactions were carried out in parallel for all mutant proteins including wild type helicase protein as a positive control and Walker A motif (G[K]{.ul}S to G[A]{.ul}S) and Walker B motif ([DE]{.ul} to [AA]{.ul}) mutants as negative controls in a 96-well plate. The assay measured amount of released phosphate during ATP hydrolysis. Activity of the wild type protein (5081 ± 167.67 picomoles of released PO~4~) was taken as 100% and comparative activities of the mutants were calculated as described in the methods. L1110F Hel (78 ± 4.3%) and V1120I Hel (69 ± 7.4%) mutant proteins showed significant decrease in the ATPase activities as compared to wild type protein (*p*  = 0.02 and *p*  = 0.005 respectively), while the double mutant L1110F/V1120I Hel showed activity (98 ± 2.3%) comparable to the wild-type helicase protein ([Table 2](#tbl0010){ref-type="table"} ).Table 2Comparative NTPase and unwinding activities of helicase mutants.Helicase protein% NTPase activity% unwinding activityL1110F Hel80.3 ± 4.3112.2 ± 10.2V1120I Hel70.4 ± 4.4[\*](#tblfn0005){ref-type="table-fn"}103.3 ± 9.7L1110F/V1120I Hel98.2 ± 2.3110.6 ± 7.5Walker A25.1 ± 3.9[\*](#tblfn0005){ref-type="table-fn"}18.6 ± 7.3[\*](#tblfn0005){ref-type="table-fn"}Walker B4.43 ± 6.9[\*](#tblfn0005){ref-type="table-fn"}0 ± 0[\*](#tblfn0005){ref-type="table-fn"}WILD100 ± 3.3100 ± 8.3[^1][^2]

Similar results were obtained when these mutants were tested for their enzyme kinetics. L1110F Hel and V1120I Hel both exhibited higher *K* ~m~ and lower *V* ~max~ values as compared to wild type enzyme indicating lowered enzymatic efficiencies of both these single mutants. While the dual mutant L1110F/V1120I Hel exhibited *K* ~m~ and *V* ~max~ values comparable to wild type enzyme indicating normal level of catalytic efficiency ([Table 3](#tbl0015){ref-type="table"} ).Table 3Enzyme kinetics (ATPase) of helicase mutants.Protein*K*~m~ (μM)*V*~max~ (nmol min^−1^ mg^−1^)L1110F Hel43.75 ± 1.72.5 ± 1.9V1120I Hel52.43 ± 3.62.6 ± 2.1L1110F/V1120I Hel36.01 ± 3.93.1 ± 2.1Walker A--1.1 ± 1.6Walker B----WILD33.62 ± 4.73.1 ± 1.2[^3]

Walker A motif and Walker B motif mutants showed negligible ATPase activities as expected (16 ± 3.9 and 0 respectively). Critical role of Walker A and B mutations in the NTPase activity of HEV helicase has been previously reported by us ([@bib0085]). We used these mutants as negative controls in the study to rule out carryover contamination of host cell NTPases during protein purification.

3.3. RNA duplex unwinding activities of helicase mutants {#sec0075}
--------------------------------------------------------

Knowing that the helicase unwinding activity requires energy generated from ATP hydrolysis, FHF helicase mutants were further assessed for RNA unwinding activity using non-radioactive quantitative assay described in the methods. This assay also included both positive and negative controls similar to ATPase assay. L1110F Hel and V1120I Hel mutants showed comparable duplex unwinding activities (106 ± 10.2 and 107 ± 9.7% respectively). While, the double mutant L1110F/V1120I Hel showed slight increase in the unwinding activity (116 ± 7.5%) ([Table 2](#tbl0010){ref-type="table"}), though not significantly higher compared to wild type protein. Overall, all three FHF mutants showed similar unwinding activities comparable to wild type protein. Walker A mutant showed 18 ± 7.3% unwinding while, Walker B motif mutant showed complete loss of RNA duplex unwinding ([Table 2](#tbl0010){ref-type="table"}). In our previous study we have shown that HEV helicase retains its ability to unwind RNA even with 40% ATPase activity as compared to wild type protein ([@bib0115]). Hence, despite some loss in the ATPase activity, L1110F Hel and V1120I Hel both mutants displayed unwinding activities comparable to wild type protein.

3.4. Replication of HEV replicon mutants {#sec0080}
----------------------------------------

We used HEV RLuc replicon to see the effect of helicase domain mutations on HEV replication. Construction of HEV RLuc subgenomic replicon by replacement of nt 5148--5816 in the ORF2 region of the genotype 1 infectious clone (pSK-HEV-2, Genbank Accession No. [AF444002](ncbi-n:AF444002){#intr0015}) with Renilla luciferase gene is reported by [@bib0030]. Complete genome sequence analysis of 7 FHF-E derived viral sequences with the pSK-HEV-2 showed overall 93--92% nucleotide identity; however, helicase domain amino acid sequences (245 aa) were completely identical in all the sequences except for the two above mentioned unique changes in FHF-E virus strains. Viral RNA dependent RNA polymerases have two conserved catalytic aspartate residues in their catalytic sites which are known to be essential for coordination of the catalytic Mg^2+^ ions during RNA polymerization. The first aspartate residue in GDD motif of HEV RdRp is essential for virus replication ([@bib0055]). We developed RdRp mutant (Mut GDD) from HEV Rluc replicon by site directed mutagenesis (G[DD]{.ul} to G[AA]{.ul}) and used as a negative control. Capped RNA transcripts were made from wild type and Mut GDD HEV Rluc replicons and transfected into S10-3 cells. Virus replication was evaluated in terms of cell associated Renilla luciferase activities, at different time points from 1 to 6 days post transfection. At 24 h, though the luciferase activity of the wild type HEV Rluc replicon was negligible (data not shown) it increased significantly 2 days onwards. The luciferase activity of Mut GDD remained negligible till 6 days without any increase from the base level values ([Fig. 3](#fig0015){ref-type="fig"}A). These results confirmed replication competence of wild type HEV Rluc replicon and negligible (no) replication of the GDD mutant in S10-3 cells.Fig. 3Replication of HEV Rluc replicon in S10-3 (Huh7) cells. (A) Replication kinetics: capped RNA transcripts of wild type and GDD mutant replicons were transfected in to the S10-3 cells, harvested at different time intervals as indicated and assayed for the dual luciferase activity. *Renilla* luciferase values were normalization with Firefly luciferase values of the respective time point. Mock sample represents cells without transfection. Bars indicate the SD of three independent transfection experiments. (B) Walker A motif and Walker B motif in the helicase domain are indispensable for HEV replication: capped RNA transcripts of wild type, Walker A mutant, Walker B mutant and GDD mutant (Mut GDD) replicons were transfected in S10-3 cells. Cells were assayed for luciferase activity to monitor the virus replication, 5 days post-transfection. Bars indicate the SD of three independent transfection experiments. (C) Negative strand RNA detection: Total RNA isolated from mock transfected, HEV Rluc, Mut GDD, Mut GKS and Mut DE RNA transfected S10-3 cells were processed for negative strand specific tag primer- based reverse transcription PCR at 48 h post-transfection. A representative 2% agarose gel of two independent experiments shows PCR product (415b p) and the lanes are -- Mock cells (1), HEV Rluc (2), Mut GDD (3), Mut GKS (4), Mut DE (5) and 100 bp DNA ladder (6). (D) Effect of FHF-E associated helicase mutations on HEV replication: S10-3 cells were transfected with wild type, Mut L1110F, Mut V1120I and Mut L1110F/V1120I replicon RNA transcripts as indicated. Transfection of Mut GDD RNA served as a negative control. Cells were assayed for renilla luciferase activity at 5 days post-transfection as described in (A). The differences between signals produced by HEV Rluc mutants and the wild-type Rluc replicon were compared by one-way analysis of variance (ANOVA).

### 3.4.1. Effect of Walker A motif and Walker B motif mutations on HEV replication {#sec0085}

Though we have previously shown that Walker A and Walker B helicase mutant proteins have negligible ATPase, RTPase and unwinding activities ([@bib0085], [@bib0090]), it was not seen how such low level enzymatic activities affect the HEV replication. For that, we developed Walker A (Mut GKS) and Walker B (Mut DE) mutants from HEV Rluc replicon by site directed mutagenesis and checked their replication efficiencies in S10-3 cells. These experiments included wild type HEV replicon as the positive control and Mut GDD as the negative control. Replication efficiency was evaluated by measuring RLuc activity in the RNA transfected cells over the period of 5 days. Mutations in both Walker A and Walker B motifs affected RLuc synthesis and there was no RLuc activity ([Fig. 3](#fig0015){ref-type="fig"}B).

RNA replication occurs through negative strand RNA intermediate, which then is used as the template for synthesis of positive sense subgenomic RNA and genomic RNA by RdRp during HEV replication. Five prime end of HEV genome encodes for the non-structural polyprotein while the capsid protein by the ORF2 region at 3′ end. As HEV-RLuc replicon was made by inserting RLuc gene into ORF2 encoding region, RLuc expression requires subgenomic RNA synthesis. Since both Walker A and Walker B mutants showed no RLuc activity there were two possibilities (1) helicase is essential during the transcription of subgenomic RNA, (2) helicase is required at the preceding step of virus replication, i.e. ns RNA (negative sense RNA) intermediate synthesis. If second possibility is true, then it will affect synthesis of both subgenomic RNA and new genomic RNA. To see whether Mut GKS and Mut DE were able to synthesize nsRNA intermediate, RNA transfected cells were harvested at 24 and 48 h post transfection and processed for strand specific RT-PCR. There was no nsRNA synthesis at both 24 and 48 h time points in both Mut GKS and Mut DE transfected cells ([Fig. 3](#fig0015){ref-type="fig"}C, lanes 4 and 5) while cells transfected with wild type HEV-RLuc were positive ([Fig. 3](#fig0015){ref-type="fig"}C, lane 2). As expected the Mut GDD also did not show any nsRNA due to lack of RdRp activity ([Fig. 3](#fig0015){ref-type="fig"}C, lane 3). These results confirmed that helicase plays a major role during nsRNA synthesis during HEV replication.

### 3.4.2. Effect of L1110F and V1120I helicase domain mutations on HEV replication {#sec0090}

To evaluate the role of FHF-E associated helicase domain mutations in HEV replication, three subgenomic replicon mutants were generated by site directed mutagenesis (Mut L1110F, Mut V1120I and Mut L1110F/V1120I). Capped RNA transcripts generated from the mutant clones were transfected into S10-3 cells and Renilla luciferase activity was measured at 5 days post-transfection. Mut V1120I replication was significantly lowered as compared to wild-type HEV Rluc replicon (*p*  = 0.0001). Mut L1110F and Mut L1110F/V1120I replicons showed comparatively better replication as compared to Mut V1120I, however, it was lower as compared to wild type replicon ([Fig. 3](#fig0015){ref-type="fig"}D). This showed that amino acid change L1110F was complementing V1120I change, since the negative effect of V1120I was at least partially rescued in the dual mutant ([Fig. 3](#fig0015){ref-type="fig"}D). Overall, luciferase activity levels of all the three mutants remained significantly lower as compared to wild type HEV replicon indicating that both FHF-E mutations in the helicase domain of the virus have negative effect on the virus replication.

4. Discussion {#sec0095}
=============

HEV entry occurs primarily via oral route however, it is not yet known how the virus reaches liver. Main target of the virus is hepatocyte, where it replicates and gets released in to bile and gastrointestinal tract. There are no cytopathic changes in the infected cells and hence causes of liver pathology and severe clinical disease are still unknown. Hepatitis E is the major cause of FHF in adults in India ([@bib0010], [@bib0110]). In addition to high mortality among pregnant women, the virus can also cause fulminant hepatitis in men and non-pregnant women ([@bib0010]).

Majority of positive sense RNA virus families encode their own RNA helicases with highly conserved sequences across different virus families. There are several studies suggesting possible involvement of viral helicases in activities other than replication. Mutations in viral helicases have been shown to alter virus replication and disease severity. A single amino acid substitution at position 249 (Thr to Pro) of the NS3 helicase region in West Nile virus (WNV) has been reported to confer a highly virulent phenotype on the viral strains otherwise weakly virulent in American crows ([@bib0025]). RNA helicase was suggested to be an attenuation or fitness determinant of WNV in different hosts ([@bib0045]). Paired mutations in virus envelope protein and NS3 helicase domain of Dengue virus were shown to synergistically enhance RNA synthesis and viral load in human and mosquito derived cell lines ([@bib0040]). Reversion of live attenuated porcine reproductive and respiratory syndrome virus vaccine strain to virulent virus by point mutations in papain-like cysteine protease and helicase regions has been reported ([@bib0135]). There are reports showing adaptive mutations in the helicase region of HCV replicons leading to better replication efficiencies in cells ([@bib0015], [@bib0105], [@bib0060]).

Multiple studies have attempted to identify hepatitis E virus associated virulence factors. Characterization of viral full genomes from FHF-E cases have shown occurrence of unique point mutations in the helicase domain of genotype 1, 3 and 4 FHF-E virus strains ([@bib0125], [@bib0070], [@bib0075], [@bib0155]). Majority of human HEV infections are caused by genotype-1 virus in developing countries. This genotype is predominantly transmitted by enteric route causing epidemics in contrast to sporadic cases caused by zoonotic transmissions of genotype-3 and genotype-4 viruses in developed countries. Associations of Th1 bias and higher HEV viral load have been documented in genotype-1 hepatitis E infections leading to FHF during pregnancy ([@bib0020]). The present study addresses effect of two point mutations (L1110F and V1120I) in the helicase domain of viral genomes from FHF-E cases from India, on the enzymatic activities of the helicase protein and virus replication. Sequence analysis of 121 HEV isolates (genotype 1--4) done by [@bib0125] showed that mutation L1110F was genotype-1 FHF specific (except for one type-4 sequence from Japan). Mutation V1120I was absent in genotype-2, predominant in genotype-3, and rare in genotype-4 HEV sequences. These dual mutations were present in 5/7 HEV genomes analyzed from FHF-E cases from India. In view of knowing critical role of helicases during positive sense RNA virus replication and recent report of [@bib0020], showing higher viral loads in FHF cases as compared to self limiting hepatitis E cases we hypothesized that these highly conserved mutations in helicase domain could be responsible for enhancing helicase enzymatic activities, which plausibly would change the magnitude of virus replication. To check this we developed three helicase protein mutants, two with individual point mutations and the third one with dual mutations and tested their signature biochemical activities.

Comparable ATPase activities were shown by L1110F and V1120I single mutants however, they were significantly less than the corresponding wild type protein activity. The dual mutant L1110F/V1120I showed ATPase activity similar to wild type protein. This suggested that these amino acid changes are complementary to each other. Despite differences in ATPase activities of the mutants, all three mutant proteins showed normal duplex unwinding activities comparable to wild-type protein. These mutations in helicase domain did not alter enzymatic activities of these proteins possibly because mutations were present in the flanking region between the conserved functional motifs IV and V of the enzyme.

We further evaluated effect of these mutations on the HEV replication using subgenomic replicon with RLuc reporter gene in hepatoma cells. Mutant V1120I showed significantly lower replication as compared to L1110F replicon. However, this negative effect of Mut V1120I was partially rescued by complementary L1110F mutation. Replication of L1110F was comparable to the dual mutant. Overall, all three FHF mutant replicons showed lower replication levels as compared to wild type replicon. This suggested that mutations in helicase domain were not increasing virus replication efficiency and there could be alternative host/viral interactions resulting in to high viral loads in FHF-E pregnant women as noted by [@bib0020]. Reduced replication efficiencies of all three mutant replicons, despite having normal levels of ATPase and unwinding activities, possibly resulted due to altered interaction/s of the helicase protein with other either viral proteins or host cell proteins. It is known that host cell factors are required in most, if not all, steps of positive-strand RNA virus infections, including entry, viral gene expression, virion assembly, and release.

Walker A motif and Walker B motifs are the most common and highly conserved motifs in helicases and play crucial role during ATP hydrolysis. We have previously reported that mutations in the Walker A and Walker B motifs significantly reduce ATPase and RNA unwinding activities of HEV helicase ([@bib0085]). In the present study we confirmed indispensable role of HEV encoded helicase during virus replication. Replacement of critical lysine residue in the Walker A motif (G[K]{.ul}S to G[A]{.ul}S) and replacement of DE to AA in the Walker B motif in the HEV-Rluc replicon resulted in complete loss of viral RNA replication of both mutants as seen by negligible levels of RLuc activities. These mutants were also unable to synthesize replicative intermediate, which is a preceding step to subgenomic RNA transcription confirming that HEV encoded helicase is essential in the initial step of viral genome replication.

In conclusion, we report importance of HEV encoded helicase domain in virus replication as Walker A and Walker B motif mutations in the helicase domain completely abolished virus replication. FHF-E associated mutations in the helicase domain did not alter helicase protein associated enzymatic activities significantly. However, corresponding mutations in the HEV subgenomic replicon significantly reduced virus replication. There is possibility of involvement of these mutations in changing viral l/host-virus protein--protein interactions, causing alterations in host responses, eventually leading to more severe disease manifestations. In absence of small animal model for HEV studies, delineating role of viral helicase in disease severity would be a big challenge. However, it will be worthwhile to see early gene responses of hepatocytes on infection with these mutant viruses.
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[^1]: Comparative activities were calculated by assuming the activity of wild type helicase as 100%. ±: standard error of the mean.

[^2]: *p* ≤ 0.05: significant difference as compared to wild type protein.

[^3]: Walker A and B mutant proteins showed variable *K*~m~ values. ±: standard deviation of the mean.
